Cash burn is likely to moderate going forward, as investments in Schrödinger's internal pipeline have now stabilized. Read ...

We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

DIsney says it has sold out all commercial inventory for Sunday's Oscars, and notes packages include TV, streaming, social ...

Full year 2024 revenue of $807 million, exceeding guidance - - All 2024 clinical and regulatory milestones were achieved on schedule, including four NDA submissions ...

PTC Therapeutics Inc (PTCT) surpasses revenue expectations, strengthens cash position, and prepares for multiple product ...

Although it reported 2024 Q4 and full-year results that beat expectations and reiterated 2025 guidance that includes ...

Novartis' dividend yield currently stands at 3.58%, which is significantly higher than that of the healthcare sector. Read ...

Q4 2024 Earnings Call Transcript February 26, 2025 Standard BioTools Inc. misses on earnings expectations. Reported EPS is $-0.09097 EPS, expectations were $-0.07. Operator: Good day, everyone, and ...

Despite a decline in total revenue, Schrodinger Inc (SDGR) showcases robust software performance and strategic collaborations ...

The polycythemia vera market over the next few years is expected to substantially change and experience growth, as it will be dominated by two already approved products, Incyte/Novartis' JAKAFI ...